RNA Holdings, LLC, also known as Mobile MedSoft, has announced the successful completion of the PrescribersConnection Long Term Care 10.6P Certification process.
SureCare RX, an independent pharmacy for long-term care facilities, is opening a new facility in Camas, WA, on April 15.
It pains me to say it, but Minnesota's done it again.
Swisslog, which offers hospital automation in material handling and medication management, and Parata Systems, a pharmacy company, have announced a partnership that will create a fully integrated outpatient pharmacy solution in the Middle East.
Most journalists immediately ask "What's in it for them?" when finding out a big company is doing something that appears moral and draws wide praise. That was certainly true of CVS Caremark's announcement Wednesday that it would stop selling cigarettes and tobacco products on Oct. 1.
Regional, national and local drug shortages are constantly changing. One month there may be a severe shortage of one item, while the next month healthcare providers have access to a steady supply. This issue causes gaps in care, and in a facility with a high-risk population to begin with, shortages could put patients' health in jeopardy.
Making decisions to outsource nonsterile packaging to a reputable, trusted partner frees up internal resources to address sterile packaging needs.
AlixaRx, a young pharmacy company, announced it is now servicing more than 100 post-acute care facilities. In less than a year in existence, AlixaRx dispensed more than 6 million doses to over 20,000 patients from its on-site dispensing systems, company officials said.
McKesson Corporation showcased new options for providers at the National Community Pharmacists Association, currently underway in Orlando.
As healthcare reform is implemented, a heightened emphasis on cost-containment is putting pressure on all healthcare providers. As hospitals determine how to reduce readmission rates and shift care to lower-cost providers, the alternate site infusion therapy sector will become even more important as a post-discharge option for patients.
UHS-Pruitt Corporation announced a new Chief Clinical Officer, Ryan "Bucky" Beddingfield. He began at UHS-Pruitt as a consultant pharmacist in 2001
AlixaRx has received a $100 million investment from Fillmore Capital Partners and be spun off from Drumm Corp., the companies said Monday.
I am getting mixed information from experienced staff members as to what has been passed along by our pharmacy company about discharging patients with their controlled and scheduled medications. No one can give me a definite answer whether this is legal or not. Can you help?
Long-term care pharmacy Skilled Care Pharmacy in Mason, OH, announced it has selected TCGRx for its medication packaging and quality control.
Long-term care nurses are like traffic cops, managing data coming at them from multiple sources. Buried in the midst of vital signs, weights, meal percentages and overly detailed reports concerning bowel movements can also be found laboratory results.
HealthMEDX recently announced that its pharmacy exchange is now available.
Most of us are familiar with the statistics: one in five Medicare patients is readmitted within 30 days, at a cost of $26 billion annually. But the personal experiences behind readmissions tell a much more compelling - and prescriptive - story about the problem.
The best med aides I've ever seen have an almost spooky knack for getting nursing home residents to take their medicine. It's an art form, really. A mystical mix of command, humor and good, old-fashioned charm.
With the backbone of an Electronic Medical Record (EMR) system in place, many providers have interfaces on their radar in order to extend the value of their investment, create a richer picture of overall resident health, eliminate inefficient double data entry, and see deeper compliance benefits.
Time is a valuable and limited resource in long-term care. Caregivers often scramble to meet the varying needs of their residents and struggle to balance those duties against equally time-consuming regulatory requirements.
With more vendors targeting the hospice market, two drug giants appear ready to face off. Walgreens left the institutional-pharmacy business in 2010, of which hospice pharmacy is a part, in a deal with Omnicare. Walgreens traded the unit for Omnicare's home-infusion business. Since then, Omnicare has been the market leader for hospice drugs. So why the strategy change for Walgreens?
Have you ever read Dr. Seuss's "Pill Drill" from "You're Only Old Once"? Wow, it's obvious he must have experienced our fragmented health system, where older adults see multiple specialists who never speak with each other and overwhelm a patient with medications they can't keep up with.
No matter your role in healthcare, medication safety is a challenge that has caused you concern. In my job as co-owner of SureCare Rx, an independently owned and operated pharmacy partner to long-term care communities in the northwestern United States, this concern is a central focus. Recently, we took bold steps to overcome common obstacles and reduce medication errors almost completely, capitalizing on cutting-edge technology to lead the way.
Readmissions are a major problem in U.S. healthcare. LTC facilities are no longer lone providers in the health of a patient, but rather are a partner in the continuum of care from the initial admission of the patient to a hospital till the patient returns to their home environment or is transferred to hospice care.
It's often the case that delivering on a simple promise involves managing a lot of complexity. To that end, we continually revisit and re-evaluate our programs and processes, looking to improve the processes that help drive clinical and operational performance.
What if compounding pharmacies were given even a quarter of the scrutiny of long-term care inspections? If that were done, I don't believe there would be a fungus among us!
The parent company of Golden Living officially launched AlixaRx with predictions it could become a $250 million per year business within 18 months.
Executives tied to one of the nation's largest nursing home chains say a new institutional pharmacy model they unveiled this week could soon become the market's No. 3 player. The parent group of Golden Living officially launched AlixaRx this week with predictions it could become a $250 million per year business within 18 months.
The headlines were big. Really big. And they involved a long-term care corporate giant settling yet another lawsuit. But they didn't tell the story I really wanted to know about. And that you probably want to know about, too.
Omnicare Inc. turned a profit in the second quarter, according to a statement from the nursing home pharmacy giant. Omnicare earned $18.7 million, or 17 cents per share, for the three months ended June 30. That compares with a loss of $1.5 million, or 1 cent per share, a year earlier. Interim Chief Executive John Workman, the company's president and chief financial officer, said the latest results reflect positive trends its generic-drugs segment and continued growth at its specialty-care business.